AI Article Synopsis

  • The study aimed to improve the use of Bone Mineral Density (BMD) tests in identifying high-risk elderly women for fractures, using 2113 women aged 75 and older from Sheffield, UK.
  • Clinical risk factors such as age, previous fractures, corticosteroid use, and low body mass index were significant in assessing fracture risk, with 16.8% classified as high risk based on these factors alone.
  • The results showed that while BMD testing identified additional high-risk individuals, it only needed to be used for about 21% of the population due to the overlap with clinical risk assessments.

Article Abstract

Introduction: The aim of this study was to develop a methodology to optimize the role of BMD measurements in a case finding strategy. We studied 2113 women > or = 75 years of age randomly selected from Sheffield, UK, and adjacent regions. Baseline assessment included hip BMD and clinical risk factors. Outcomes included death and fracture in women followed for 6723 person-years.

Materials And Methods: Poisson models were used to identify significant risk factors for all fractures and for death with and without BMD and the hazard functions were used to compute fracture probabilities. Women were categorized by fracture probability with and without a BMD assessment. A 10-year fracture probability threshold of 35% was taken as an intervention threshold. Discordance in categorization of risk (i.e., above or below the threshold probability) between assessment with and without BMD was examined by logistic regression as probabilities of re-classification. Age, prior fracture, use of corticosteroids, and low body mass index were identified as significant clinical risk factors.

Results: A total of 16.8% of women were classified as high risk based on these clinical risk factors. The average BMD in these patients was approximately 1 SD lower than in low-risk women; 21.5% of women were designated to be at high risk with the addition of BMD. Fifteen percent of all women were reclassified after adding BMD to clinical risk factors, most of whom lay near the intervention threshold. When a high probability of reclassification was accepted (without a BMD test) for high risk to low risk (p1< or = 0.8) and a low probability accepted for low to high risk (P2 < or = 0.2), BMD tests would be required in only 21% of the population.

Conclusion: We conclude that the use of clinical risk factors can identify elderly women at high fracture risk and that such patients have a low average BMD. BMD testing is required, however, in a minority of women--a fraction that depends on the probabilities accepted for classification and the thresholds of risk chosen. These findings need to be validated in other cohorts at different ages and from different regions of the world.

Download full-text PDF

Source
http://dx.doi.org/10.1359/jbmr.2004.19.6.906DOI Listing

Publication Analysis

Top Keywords

high risk
20
clinical risk
20
risk factors
20
risk
15
bmd
12
bmd measurements
8
women
8
bmd clinical
8
fracture probability
8
intervention threshold
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!